ACUTE SPINAL CORD INJURY (SCI)
Clinical trials for ACUTE SPINAL CORD INJURY (SCI) explained in plain language.
Never miss a new study
Get alerted when new ACUTE SPINAL CORD INJURY (SCI) trials appear
Sign up with your email to follow new studies for ACUTE SPINAL CORD INJURY (SCI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental spinal cord injury drug offered before approval
Disease control AVAILABLEThis program provides early access to an investigational drug called Elezanumab for people with acute spinal cord injury before it is officially approved. It is for patients who have no other suitable treatment options and cannot join ongoing clinical trials. A doctor must determ…
Matched conditions: ACUTE SPINAL CORD INJURY (SCI)
Sponsor: AbbVie • Aim: Disease control
Last updated Apr 02, 2026 00:26 UTC
-
Migraine pill could help spinal cord injury recovery
Disease control Recruiting nowThis early-stage trial is testing whether a drug already used for migraines (Eletriptan, called TZ-161 in this study) can help people recover from a recent, traumatic spinal cord injury. The goal is to see if the drug is safe and well-tolerated in this new situation and to gather…
Matched conditions: ACUTE SPINAL CORD INJURY (SCI)
Phase: PHASE1, PHASE2 • Sponsor: Technophage, SA • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC